AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Prophylactic Surgery May Be Too Late for Ovarian Ca.

OB GYN News

| May 01, 2001 | JOHNSON, KATE | COPYRIGHT 2001 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Five of 60 women had disease at surgery.

NASHVILLE, TENN. -- For women at high risk of developing ovarian cancer, prophylactic oophorectomy may sometimes come too late.

And a full hysterectomy, in addition to a bilateral salpingo-oophorectomy, should be the standard of care for these at-risk patients, Dr. Joan Murphy said at the annual meeting of the Society for Gynecologic Oncology.

In a study of 60 patients with a BRCAI mutation who underwent the procedure at about 48 years of age, 5 patients already had the disease. Four of the cancers were invasive; one was carcinoma in situ.

"There's growing evidence that this is becoming an issue, and I think we have probably underplayed it," said Dr. Murphy one of the study investigators and head of the division of gynecologic oncology at the Familial Ovarian Cancer Center, Princess Margaret Hospital, Toronto.

"Although this procedure is prophylactic and we go into it believing that these women are well, in all five of our cases it's come as a terrible shock to them to find out they already had cancer," she told this newspaper.

Dr. Murphy strongly advised very careful preoperative counseling of these women, suggesting that most physicians in this field may be underestimating the risks of finding an occult cancer.

Related articles from newspapers, magazines, journals, and more
Pivotal Registration Trial of OPAXIO Maintenance Therapy in First-Line Ovarian...
Press release article from: PR Newswire September 22, 2009 700+ words
...maintenance therapy for ovarian cancer. The Gynecologic Oncology Group (GOG...milestone in the ovarian cancer trial enrollment...effective in ovarian cancer, esophageal...potential that the Gynecologic Oncology Group will not...
High Dose, Single-Agent XYOTAX(TM) to Be Tested in Treating Recurrent and...
Press release article from: PR Newswire August 14, 2002 700+ words
...Inc. (CTI) announced that the Gynecologic Oncology Group (GOG), a cooperative of many...treating patients who have recurrent ovarian cancer, including those who are taxane...at the 175 mg/m2 dose in salvage ovarian cancer, using a higher does in less heavily...
Reports from Catholic University, Division of Gynecologic Oncology describe...
Newspaper article from: Cancer Weekly October 20, 2009 700+ words
...cytoreduction in ovarian cancer," researchers...see also Ovarian Cancer Prevention...enrolled at the Gynecologic Oncology Unit, Catholic...Division of Gynecologic Oncology. The researchers...to predict ovarian cancer optimal cytoreduction...
Gynecologic Oncology Group to conduct phase III trial of Xyotax.(ovarian cancer...
Magazine article from: Women's Health Weekly December 12, 2002 700+ words
...CTI) (CTIC) and the Gynecologic Oncology Group (GOG) announced...front-line treatment of ovarian cancer. The trial is expected...the lives of women with ovarian cancer, one of our biggest challenges...United States will develop ovarian cancer and will live, on average...
Gynecologic Oncology Group to Conduct Front-Line Phase III Trial of XYOTAX(TM)...
Press release article from: PR Newswire November 5, 2002 700+ words
...and the Gynecologic Oncology Group (GOG...treatment of ovarian cancer. The trial...phase III ovarian cancer trial. This...About The Gynecologic Oncology Group The...standards for ovarian cancer, demonstrating...
Cell Therapeutics, Inc. and GOG Sign Landmark Agreement for Phase III...
Press release article from: PR Newswire April 1, 2004 700+ words
...and the Gynecologic Oncology Group (GOG...patients with ovarian cancer. This represents...advanced ovarian cancer. The standard...About The Gynecologic Oncology Group The...standards for ovarian cancer, demonstrating...
Gynecologic oncology: S-P's Caelyx in platinum-sensitive ovarian...
Newspaper article from: Pharma Marketletter March 6, 2006 700+ words
...with platinum-sensitive recurrent ovarian cancer were discussed at a conference symposium...Treatment challenges in recurrent ovarian cancer," organized by US drug major Schering...for recurrent platinum-sensitive ovarian cancer. The expectation is that the new treatment...
Gynecologic Oncology Group to conduct phase III trial of Xyotax.
Newspaper article from: Drug Week December 13, 2002 700+ words
...CTI) (CTIC) and the Gynecologic Oncology Group (GOG) announced...front-line treatment of ovarian cancer. The trial is expected...the lives of women with ovarian cancer, one of our biggest challenges...United States will develop ovarian cancer and will live, on average...
For more facts and information, see all results

Source: HighBeam Research, Prophylactic Surgery May Be Too Late for Ovarian Ca.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA